Clinical Trials Browser

Phase 2 × Central Nervous System Neoplasms × Gadolinium × Clear all

NCT03270059 2026-02-27

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Phase 2 Recruiting

Brain Neoplasms, Cranial Nerve Diseases, Central Nervous System Neoplasms